Sutro Biopharma (STRO) Change in Receivables (2017 - 2025)
Historic Change in Receivables for Sutro Biopharma (STRO) over the last 9 years, with Q3 2025 value amounting to -$4.1 million.
- Sutro Biopharma's Change in Receivables fell 128203.39% to -$4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.7 million, marking a year-over-year increase of 7259.33%. This contributed to the annual value of -$27.5 million for FY2024, which is 19484.04% down from last year.
- According to the latest figures from Q3 2025, Sutro Biopharma's Change in Receivables is -$4.1 million, which was down 128203.39% from -$5.6 million recorded in Q2 2025.
- In the past 5 years, Sutro Biopharma's Change in Receivables registered a high of $86.0 million during Q2 2022, and its lowest value of -$86.4 million during Q3 2022.
- Moreover, its 5-year median value for Change in Receivables was $126000.0 (2023), whereas its average is -$86631.6.
- In the last 5 years, Sutro Biopharma's Change in Receivables skyrocketed by 434826.69% in 2022 and then crashed by 1942539.68% in 2024.
- Over the past 5 years, Sutro Biopharma's Change in Receivables (Quarter) stood at $124000.0 in 2021, then tumbled by 3429.03% to -$4.1 million in 2022, then skyrocketed by 571.2% to $19.5 million in 2023, then tumbled by 89.92% to $2.0 million in 2024, then plummeted by 307.9% to -$4.1 million in 2025.
- Its Change in Receivables was -$4.1 million in Q3 2025, compared to -$5.6 million in Q2 2025 and $4.9 million in Q1 2025.